Author:
Lessi Francesca,Mazzanti Chiara Maria,Tomei Sara,Di Cristofano Claudio,Minervini Andrea,Menicagli Michele,Apollo Alessandro,Masieri Lorenzo,Collecchi Paola,Minervini Riccardo,Carini Marco,Bevilacqua Generoso
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference29 articles.
1. Ficarra V, Schips L, Guille F, Li G, De La Taille A, Prayer Galetti T, et al. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma. Cancer. 2005;104(5):968–74. doi: 10.1002/cncr.21254 .
2. Brauch H, Weirich G, Brieger J, Glavac D, Rodl H, Eichinger M, et al. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation. Cancer Res. 2000;60(7):1942–8.
3. Foster K, Crossey PA, Cairns P, Hetherington JW, Richards FM, Jones MH, et al. Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer. 1994;69(2):230–4.
4. Iliopoulos O, Ohh M, Kaelin WG Jr. pVHL19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation. Proc Natl Acad Sci USA. 1998;95(20):11661–6.
5. Shen C, Kaelin WG Jr. The VHL/HIF axis in clear cell renal carcinoma. Semin Cancer Biol. 2013;23(1):18–25. doi: 10.1016/j.semcancer.2012.06.001 .
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献